Simple jQuery Dropdowns

Browsing by Author I. Gathmann

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Jan-2000Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malariaM. Van Vugt; S. Looareesuwan; P. Wilairatana; R. McGready; L. Villegas; I. Gathmann; R. Mull; A. Brockman; N. J. White; F. Nosten; Shoklo Malaria Research Unit; Academic Medical Centre, University of Amsterdam; Mahidol University; Ministry of Health; Novartis International AG; John Radcliffe Hospital
1-Jun-1999Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malariaM. Van Vugt; P. Wilairatana; B. Gemperli; I. Gathmann; L. Phaipun; A. Brockman; C. Luxemburger; N. J. White; F. Nosten; S. Looareesuwan; Shoklo Malaria Research Unit; Mahidol University; Novartis International AG
1-Jan-1999No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrineM. Van Vugt; F. Ezzet; F. Nosten; I. Gathmann; P. Wilairatana; S. Looareesuwan; N. J. White; Shoklo Malaria Research Unit; Academic Medical Centre, University of Amsterdam; Novartis International AG; John Radcliffe Hospital; Mahidol University
1-Jan-1998Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malariaM. Van Vugt; A. Brockman; B. Gemperli; C. Luxemburger; I. Gathmann; C. Royce; Thra Slight; S. Looareesuwan; N. J. White; F. Nosten; Shoklo Malaria Research Unit; Academic Medical Centre, University of Amsterdam; Mahidol University; Novartis International AG; John Radcliffe Hospital
1-Jan-1999A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in ThailandS. Looareesuwan; P. Wilairatana; W. Chokejindachai; K. Chalermrut; W. Wernsdorfer; B. Gemperli; I. Gathmann; C. Royce; Mahidol University; Universitat Wien; Novartis International AG